2025 Future Leaders in Psoriatic Disease

Formerly known as Dermatology Residents' and Rheumatology Fellows' Meeting

A collection of photos from the Annual Dermatology Residents' and Rheumatology Fellows Meeting: a panel on stage, Dr. Lebwohl, a poster session, and attendees.

The 2025 Future Leaders in Psoriatic Disease, now in its 27th year, will be held on Saturday, October 4, and Sunday, October 5, at the Renaissance Hotel in Dallas, Texas.

This esteemed event brings together dermatology residents and rheumatology fellows for an intensive two-day educational event focused on the latest advancements in treating and managing psoriasis and psoriatic arthritis. The meeting's agenda includes networking and cross-disciplinary training, aimed at equipping dermatologists with enhanced skills to screen for and manage psoriatic arthritis, and offering rheumatologists comprehensive insights into managing the skin manifestations of psoriatic disease.

Future Leaders in Psoriatic Disease, formerly known as the Dermatology Residents' and Rheumatology Fellows' Meeting, was founded in 1999 by Mark G. Lebwohl, M.D., of the Icahn School of Medicine at Mount Sinai and chair emeritus of the NPF medical board.

Applications Are Open

Travel and Lodging Information. Applications are due by June 16. Applicants will be notified of selection decisions by the beginning of July, 2025.

Questions? Email us at medicalaffairs@psoriasis.org.

Apply now

Applications are open now for this dynamic two-day program offering a comprehensive curriculum on psoriatic disease.

Our event features evidence-based sessions led by top experts in psoriasis and psoriatic arthritis, providing a detailed overview of the clinical, medical, psychosocial, and economic impacts of psoriasis and its management.

Highlights include:

  • Review of recent advances in the treatment of psoriasis, psoriatic arthritis, and comorbid conditions.
  • In-depth exploration of strategies for diagnosing and managing psoriatic disease in skin of color and special patient populations.
  • Examination of strategies to reduce costs and barriers associated with psoriatic disease treatment options.
  • Networking opportunities with peers, industry partners, and leading academic healthcare providers from various practice settings across the U.S.

2025 Co-Chairs

Wilson Liao, M.D., University of California, San Francisco

Wilson Liao, M.D., University of California, San Francisco

Dermatology Co-Chair

Alexis Ogdie, MD, MSCE

Alexis Odgie, M.D., MSCE, Hospital of the University of Pennsylvania

Rheumatology Co-Chair

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.